About Published works Copywriting, translation, speaking, and training Contact

Journalist with a decade's experience writing and editing science news, opinion, features, and investigations. 

Words in Business Insider, BBC Science Focus, Live Science, The British Medical Journal, The Lancet, Nature Medicine, and others.

I turn around factchecked, tight, readable copy within the deadline without compromising on accuracy. I write for a range of audiences, from broadsheet news readers, to B2B, to high-level policymakers.

I have more than 700 bylines to my name, which have attracted tens of millions of pageviews. 

I have expertise in a variety of beats in science and health. At the moment, on the science-y side, I am particularly fascinated by obesity and overweight and the interaction of fat with the metabolism. On the policy side, I am keen to dig into power structures and funding of science.

Click to search my archive

Featured articles

News features 

Nature Medicine •

The damage done - Nature Medicine

When clinical trials are suddenly halted by US funding cuts, there are repercussions for investigators and patients, and they do not stop at borders.
In just one day, the Botswana Harvard Health Partnership — a research collaboration with nearly 300 staff — went from world-leading hub to crisis mode. On 15 May 2025, Roger Shapiro, professor at the Harvard T.H. Chan School of Public Health in Boston, and his colleagues lost seven US National Institutes of Health (NIH) grants that supported 11 trials, staff, mentoring and patients enrolled in those trials.
European Union, 2019
European Commissioner Olivér Várhelyi speaks at Brussels - EP, Brussels - European Parliament
The Lancet •

New EU Health Commissioner appointed amid controversy

Olivér Várhelyi's tempestuous confirmation process has seen pandemic preparedness and reproductive health stripped from his portfolio. Marianne Guenot reports.
Europe has a new Commissioner for Health and Animal Welfare. Olivér Várhelyi, the former European Commissioner for Neighbourhood and Enlargement, began his term on Dec 1, as part of European Commission President Ursula von der Leyen's second College of Commissioners.
The new role for Hungary's Várhelyi was among the most disputed, with Members of the European Parliament (MEPs) raising his connection to President Viktor Orbán and the controversial right-wing Fidesz party during his confirmation. Negotiations eventually led to sexual and reproductive health and pandemic preparedness being stripped from Várhelyi's portfolio.
Business Insider •

Long COVID patients: We feel gaslit by doctors that still don't believe us

For some long COVID patients, going to the doctor's office requires a clear game plan, extensive research, mental resilience, and physical stamina. That's because they don't expect their doctors to believe them.

Patients with other diseases that are poorly understood, like chronic fatigue syndrome or fibromyalgia, are familiar with medical gaslighting, a term for situations in which medical professionals undermine or dismiss a patient's symptoms as being caused by stress or anxiety.

Science explainers

British Medical Journal (BMJ) •

How do GLP-1 drugs work for weight loss . . . and everything else?

Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Wegovy/Ozempic) are constantly in the news for their staggering slimming effects. But it’s becoming clear that there is more to this drug class than weight loss.GLP-1 receptor agonists were once thought to be simple insulin regulators. Now, they’re known to act on the kidneys, heart, liver, brain, and more. “I think it’s absolutely fascinating and definitely very unusual that the potential indications are expanding so dramatical...
Nature Medicine •

Can quantum computing crack the biggest challenges in health?

Cleveland Clinic in the USA and the
UK National Health Service are both part of a burgeoning community of researchers, health systems and companies exploring applications of quantum computing in health. Although this nascent technology is at least a few years away from having practical applications — and some are warning of the
impending burst of the ‘quantum bubble’ —
many experts believe that biomedical and
healthcare research needs to be ready for the
quantum revolution of tomorrow.
“I know we are taking a gamble,” says
Lara Jehi, Cleveland Clinic’s chief research
information officer, who leads the institute’s
quantum research. Jehi hopes that “there is a
strategic, long-term advantage in being the
group that was first.”

Deep dives

Business Insider •

Over 600 cubes of Nazi uranium made their way to the US after the war. 2 scientists are trying to figure out where they are now.

These paperweight-like cubes wouldn't raise an eyebrow on someone's desk.

"Marie Curie's granddaughter has one. She uses it as a doorstop," said an expert.

But these 2-inch uranium cubes were once important enough for the Allied forces to send a special task force, codenamed 'Alsos' to bring them back from Nazi Germany.

This story follows two science sleuths as they trace fourteen hand-sized uranium cubes back to Nazi Germany's first efforts to build a nuclear reactor, and the Manhattan Project's attempts to derail this plan.
Business Insider •

A Harvard professor is risking his reputation to search for aliens. Tech tycoons are bankrolling his quest.

Harvard's Avi Loeb has been setting the astrophysics world on fire with his claims that extraterrestrial tech could be behind recent near-Earth observations, his rising public persona, and his upcoming off-Broadway one-man show.

In this story, I spoke to the controversial professor to understand his motivation to search for signs of alien intelligence in Earth's backyard. I also investigated how he piqued the interest of wealthy counter-culture philanthropists to fund his quest.
Business Insider •

The moon is open for business, and entrepreneurs are racing to make billions

The moon could soon represent a market worth over $100 billion, piquing the interests of private companies like SpaceX, Blue Origin, Nokia, Lockheed Martin, and General Motors, to develop solutions for its lunar missions such as space-worthy rides, moon streaming, lunar GPS, and more.

This new market — worth over $100 billion— could be game-changing for humanity.

"Definitely the moon is going to be a big business," said Prachi Kawade, a senior analyst at NSR, a research-and-consulting company focused on the space market.
Photo by Suzy Hazelwood on Pexels

Subscribe to get my new articles by email

Get an email (max one a week) when I publish articles on my portfolio. Unsubscribe anytime.

Follow Me